Randall B. Brenner - Net Worth and Insider Trading

Randall B. Brenner Net Worth

The estimated net worth of Randall B. Brenner is at least $925,916 dollars as of 2024-11-05. Randall B. Brenner is the Chief Development & Regulatory of Paratek Pharmaceuticals Inc and owns about 415,209 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $925,916. Details can be seen in Randall B. Brenner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randall B. Brenner has not made any transactions after 2023-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Randall B. Brenner

To

Randall B. Brenner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randall B. Brenner owns 1 companies in total, including Paratek Pharmaceuticals Inc (PRTK) .

Click here to see the complete history of Randall B. Brenner’s form 4 insider trades.

Insider Ownership Summary of Randall B. Brenner

Ticker Comapny Transaction Date Type of Owner
PRTK Paratek Pharmaceuticals Inc 2023-09-21 Chief Development & Regulatory

Randall B. Brenner Latest Holdings Summary

Randall B. Brenner currently owns a total of 1 stock. Randall B. Brenner owns 415,209 shares of Paratek Pharmaceuticals Inc (PRTK) as of August 9, 2023, with a value of $925,916.

Latest Holdings of Randall B. Brenner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRTK Paratek Pharmaceuticals Inc 2023-08-09 415,209 2.23 925,916

Holding Weightings of Randall B. Brenner


Randall B. Brenner Form 4 Trading Tracker

According to the SEC Form 4 filings, Randall B. Brenner has made a total of 12 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 27,603 shares on August 9, 2023, which brought Randall B. Brenner around $60,727.

Insider Trading History of Randall B. Brenner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Randall B. Brenner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Randall B. Brenner Ownership Network

Ownership Network List of Randall B. Brenner

No Data

Ownership Network Relation of Randall B. Brenner

Insider Network Chart

Randall B. Brenner Owned Company Details

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Randall B. Brenner is the Chief Development & Regulatory of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and director & CEO Evan Loh .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Randall B. Brenner made 1 insider transaction in Paratek Pharmaceuticals Inc (PRTK) with a net sale of 27,603. Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

Randall B. Brenner Mailing Address

Above is the net worth, insider trading, and ownership report for Randall B. Brenner. You might contact Randall B. Brenner via mailing address: C/o Paratek Pharmaceuticals, Inc., 75 Park Plaza, 4th Floor, Boston Ma 02116.